dr. graff discusses sipuleucel-t in patients with mcrpc
Published 6 years ago • 82 plays • Length 0:48Download video MP4
Download video MP3
Similar videos
-
0:48
dr. graff discusses the treatment of prostate cancer
-
0:58
dr. graff on the role of checkpoint inhibitors in prostate cancer
-
0:50
dr. graff on the keynote-641 trial in mcrpc
-
1:08
dr. graff on the use of abiraterone in metastatic prostate cancer
-
5:07
sipuleucel-t in castration-resistant prostate cancer
-
1:56
dr. antonarakis on sipuleucel-t plus radium-223 in bone-metastatic crpc
-
0:56
dr. armstrong on sipuleucel-t in prostate cancer
-
6:25
dr. george discusses radium-223 for patients with mcrpc part i
-
1:16
dr. sartor on the implications of the analysis of sipuleucel-t in prostate cancer
-
8:21
ep. 10: how has the mcrpc treatment landscape changed?
-
0:51
dr. sartor on the next steps with sipuleucel-t for prostate cancer
-
1:04
dr. grivas on potential combinations with cabazitaxel in prostate cancer
-
4:42
dr. george discusses radium-223 for patients with mcrpc part ii
-
6:11
sipuleucel-t: evidence-based use
-
1:20
dr. sartor on provenge in combination with radium-223
-
8:09
treating mcrpc with newer hormonal agents
-
1:20
dr. antonarakis on trial examining sipuleucel-t plus radium-223 in bone-metastatic crpc
-
1:10
dr. daniel petrylak discusses chemotherapy in prostate cancer
-
23:12
prostate cancer | dr. tony talebi discusses treatment of stage 4 hormone resistant prostate cancer